Valuation ratios measure the quantity of an asset or flaw (e.g., earnings) associated with ownership of a specified claim (e.g., a share of ownership of the enterprise).

Current Valuation Ratios
Historical Valuation Ratios (Summary)
Price to Earnings (P/E)
Price to Operating Profit (P/OP)
Price to Sales (P/S)
Price to Book Value (P/BV)

McKesson Corp., current price multiples

	McKesson Corp.		Abbott Laboratories	Cigna Group	CVS Health Corp.	Elevance Health Inc.	Humana Inc.	Intuitive Surgical Inc.	Medtronic PLC	UnitedHealth Group Inc.
Selected Financial Data
Current share price (P)
No. shares of common stock outstanding
Growth rate (g)

Earnings per share (EPS)
Next year expected EPS
Operating profit per share
Sales per share
Book value per share (BVPS)
Valuation Ratios (Price Multiples)
Price to earnings (P/E)
Price to next year expected earnings
Price-earnings-growth (PEG)
Price to operating profit (P/OP)
Price to sales (P/S)
Price to book value (P/BV)

Based on: 10-K (reporting date: 2016-03-31).

If the company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued.
Otherwise, if the company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued.

McKesson Corp., historical price multiples

		Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011
	Price to earnings (P/E)
	Price to operating profit (P/OP)
	Price to sales (P/S)
	Price to book value (P/BV)

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

Download chart

Valuation ratio	Description	The company
P/E ratio	The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings.	McKesson Corp. P/E ratio increased from 2014 to 2015 but then decreased significantly from 2015 to 2016.
P/OP ratio	Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit.	McKesson Corp. P/OP ratio increased from 2014 to 2015 but then decreased significantly from 2015 to 2016.
P/S ratio	An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative.	McKesson Corp. P/S ratio decreased from 2014 to 2015 and from 2015 to 2016.
P/BV ratio	The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return.	McKesson Corp. P/BV ratio increased from 2014 to 2015 but then decreased significantly from 2015 to 2016.

McKesson Corp., historical P/E calculation, comparison to benchmarks

		Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011
	No. shares of common stock outstanding¹
	Selected Financial Data (US$)
	Net income attributable to McKesson Corporation (in millions)
	Earnings per share (EPS)²
	Share price^1, 3
	Valuation Ratio
	P/E ratio⁴
	Benchmarks
	P/E Ratio, Competitors⁵
	Abbott Laboratories
	Cigna Group
	CVS Health Corp.
	Elevance Health Inc.
	Humana Inc.
	Intuitive Surgical Inc.
	Medtronic PLC
	UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

¹ Data adjusted for splits and stock dividends.

² 2016 Calculation
EPS = Net income attributable to McKesson Corporation ÷ No. shares of common stock outstanding
= ÷ =

³ Closing price as at the filing date of McKesson Corp. Annual Report.

⁴ 2016 Calculation
P/E ratio = Share price ÷ EPS
= ÷ =

⁵ Click competitor name to see calculations.

Download chart

Valuation ratio	Description	The company
P/E ratio	The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings.	McKesson Corp. P/E ratio increased from 2014 to 2015 but then decreased significantly from 2015 to 2016.

McKesson Corp., historical P/OP calculation, comparison to benchmarks

		Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011
	No. shares of common stock outstanding¹
	Selected Financial Data (US$)
	Operating income (in millions)
	Operating profit per share²
	Share price^1, 3
	Valuation Ratio
	P/OP ratio⁴
	Benchmarks
	P/OP Ratio, Competitors⁵
	Abbott Laboratories
	Cigna Group
	CVS Health Corp.
	Elevance Health Inc.
	Humana Inc.
	Intuitive Surgical Inc.
	Medtronic PLC
	UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

¹ Data adjusted for splits and stock dividends.

² 2016 Calculation
Operating profit per share = Operating income ÷ No. shares of common stock outstanding
= ÷ =

³ Closing price as at the filing date of McKesson Corp. Annual Report.

⁴ 2016 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= ÷ =

⁵ Click competitor name to see calculations.

Download chart

Valuation ratio	Description	The company
P/OP ratio	Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit.	McKesson Corp. P/OP ratio increased from 2014 to 2015 but then decreased significantly from 2015 to 2016.

McKesson Corp., historical P/S calculation, comparison to benchmarks

		Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011
	No. shares of common stock outstanding¹
	Selected Financial Data (US$)
	Revenues (in millions)
	Sales per share²
	Share price^1, 3
	Valuation Ratio
	P/S ratio⁴
	Benchmarks
	P/S Ratio, Competitors⁵
	Abbott Laboratories
	Cigna Group
	CVS Health Corp.
	Elevance Health Inc.
	Humana Inc.
	Intuitive Surgical Inc.
	Medtronic PLC
	UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

¹ Data adjusted for splits and stock dividends.

² 2016 Calculation
Sales per share = Revenues ÷ No. shares of common stock outstanding
= ÷ =

³ Closing price as at the filing date of McKesson Corp. Annual Report.

⁴ 2016 Calculation
P/S ratio = Share price ÷ Sales per share
= ÷ =

⁵ Click competitor name to see calculations.

Download chart

Valuation ratio	Description	The company
P/S ratio	An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative.	McKesson Corp. P/S ratio decreased from 2014 to 2015 and from 2015 to 2016.

McKesson Corp., historical P/BV calculation, comparison to benchmarks

		Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011
	No. shares of common stock outstanding¹
	Selected Financial Data (US$)
	Total McKesson Corporation stockholders’ equity (in millions)
	Book value per share (BVPS)²
	Share price^1, 3
	Valuation Ratio
	P/BV ratio⁴
	Benchmarks
	P/BV Ratio, Competitors⁵
	Abbott Laboratories
	Cigna Group
	CVS Health Corp.
	Elevance Health Inc.
	Humana Inc.
	Intuitive Surgical Inc.
	Medtronic PLC
	UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

¹ Data adjusted for splits and stock dividends.

² 2016 Calculation
BVPS = Total McKesson Corporation stockholders’ equity ÷ No. shares of common stock outstanding
= ÷ =

³ Closing price as at the filing date of McKesson Corp. Annual Report.

⁴ 2016 Calculation
P/BV ratio = Share price ÷ BVPS
= ÷ =

⁵ Click competitor name to see calculations.

Download chart

Valuation ratio	Description	The company
P/BV ratio	The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return.	McKesson Corp. P/BV ratio increased from 2014 to 2015 but then decreased significantly from 2015 to 2016.

	McKesson Corp.	Other companies (not purchased previously)
Stock Price Trends
Financial Statements
Common-Size Financial Statements
Analysis of Financial Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Long-term Trends
Analysis of Components of Financial Statements
Financial Reporting Quality

	All companies
Stock Price Trends
Financial Statements
Common-Size Financial Statements
Analysis of Financial Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Long-term Trends
Analysis of Components of Financial Statements
Financial Reporting Quality

McKesson Corp. (NYSE:MCK)

Common Stock Valuation Ratios (Price Multiples)

Paying users area

Try for free

Current Valuation Ratios

Historical Valuation Ratios (Summary)

Price to Earnings (P/E)

Price to Operating Profit (P/OP)

Price to Sales (P/S)

Price to Book Value (P/BV)